TEG® 6s肝素中和盒用于对接受心血管外科手术的患者进行静血评估
Dieter Adelmann1, Jan Hartmann2, Hunter B Moore3
1Department of Anesthesia and Perioperative Care, University of California, San Francisco, California.
Anesthesiology
|September 18, 2025
概括
这项研究验证了TEG 6s肝素中和盒,用于在接受肝素的患者进行准确的治疗点凝血测试. 经过验证的盒子为接受重大心血管手术的肝素化患者提供可靠的结果.
科学领域:
- 凝血科学 凝血科学
- 医疗器械验证 医疗器械验证
- 照顾点检测检测 照顾点检测
背景情况:
- 氨酸的使用可能会干扰血液凝固的标准粘弹性测试.
- 该TEG 6s系统使用一个肝酶弹来中和肝的作用.
- 需要先前对TEG 6s系统进行验证,以对肝化患者进行验证.
研究的目的:
- 为了临床验证TEG 6s全球静血-肝素中和盒.
- 在接受心血管外科手术或手术的肝素化患者中评估卡的性能.
- 与标准方法相比,评估含有肝酶的试验的准确性.
主要方法:
- 一项多中心观察性研究包括了接受未分离肝素的成年患者.
- 血液样本是在原蛋白前,原蛋白后和原蛋白逆转后收集的.
- 对氨酸中和子的测试与使用线性回归和相关性分析的引用多通道子的测试进行了比较.
主要成果:
- 德明回归倾斜率大约为1.0,表明弹之间有很强的一致性.
- 在不同试验之间观察到高的皮尔森相关系数 (0.79-0.96).
- 功能性纤维激素试验与血纤维激素水平有很好的相关性 (斯皮尔曼相关性,0.68).
结论:
- 该TEG 6s氨酸中和盒在临床上已被验证用于在肝素化患者的治疗点凝血测试.
- 卡在接受心血管手术和手术的患者中表现出可靠的性能.
- 建议进行进一步的前性试验,以确定这种的临床实用性.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.7K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.7K
01:26Cardiac Catheterization IV: Nursing Management
660
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
660